OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Clinical trials for OVARIAN CLEAR CELL ADENOCARCINOFIBROMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL ADENOCARCINOFIBROMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL ADENOCARCINOFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new combo to fight back when ovarian cancer returns
Disease control OngoingThis large, late-stage trial is for people whose ovarian, fallopian tube, or primary peritoneal cancer has returned after initial successful treatment. It aims to find the best way to control the cancer by testing whether adding a drug called bevacizumab to standard chemotherapy,…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major trial tests if weekly chemo beats standard schedule for tough cancers
Disease control OngoingThis large, Phase 3 trial aimed to find out if giving a key chemotherapy drug (paclitaxel) once a week is better than giving it once every three weeks for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. All patients also received another standard che…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC